Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE‑590 study - Kato, K; Sun, J; Shah, M A (Ann Oncol, 2020)
; Abstract LBA8_PR